Home › NDC Lookup › Ingredients › Octinoxate And Titanium Dioxide › 58411-0571-10
SHISEIDO SYNCHRO SKIN RADIANT LIFTING FOUNDATION 230 OCTINOXATE and TITANIUM DIOXIDE 2.484 g/30mL; .36 g/30mL Emulsion — NDC 58411-0571-10 package photo

SHISEIDO SYNCHRO SKIN RADIANT LIFTING FOUNDATION 230 OCTINOXATE and TITANIUM DIOXIDE 2.484 g/30mL; .36 g/30mL Emulsion

by SHISEIDO AMERICAS CORPORATION · 1 BOTTLE in 1 CARTON (58411-571-10) / 30 mL in 1 BOTTLE
NDC 58411-0571-10
🏷️ FDA NDC (as labeled) 58411-571-10 billing pads the product segment with a zero
OTC On market Non-controlled
🗂️ Data synced Aug 20, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

🆔 Identity & classification

FDA NDC (as labeled) 58411-571-10
Product NDC 58411-571
11-digit billing NDC 58411057110
UNII 4Y5P7MUD51, 15FIX9V2JP
Application # M020
SPL Set ID 8a0da327-a805-4ef9-b69a-14bf7278a81a
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2020-09-20
Route TOPICAL
Dosage form EMULSION
Substance OCTINOXATE; TITANIUM DIOXIDE
Why two NDCs? The FDA registers this code as 58411-571-10 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 58411-0571-10. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

🏭 Manufacturer & labeler

LabelerSHISEIDO AMERICAS CORPORATION
FDA applicationM020 (OTC MONOGRAPH DRUG)
Labeler code58411
First marketedSep 2020
Product typeHuman Otc Drug
Portfolio361 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

🩺 Clinical

🧪 What is this product?

This is an over-the-counter liquid foundation makeup marketed as an OTC monograph product. It contains two active ingredients commonly used as UV filters: octinoxate and titanium dioxide. These minerals and chemical compounds are typically used together in cosmetic and personal care products to help protect skin from ultraviolet light exposure when applied topically to the face.

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

🧪 Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

💲 Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer mLPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

🔁 Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Shiseido Synchro Skin Radiant Lifting Foundation 130 2.484 g/30mL; .36 g/30mL 58411-0565-10 SHISEIDO 1 bottle — — FDA listed —
Shiseido Synchro Skin Radiant Lifting Foundation 240 2.484 g/30mL; .36 g/30mL 58411-0572-10 SHISEIDO 1 bottle — — FDA listed —
Shiseido Synchro Skin Radiant Lifting Foundation 260 2.484 g/30mL; .36 g/30mL 58411-0574-10 SHISEIDO 1 bottle — — FDA listed —
Shiseido Synchro Skin Radiant Lifting Foundation 210 2.484 g/30mL; .36 g/30mL 58411-0569-10 SHISEIDO 1 bottle — — FDA listed —
Shiseido Synchro Skin Radiant Lifting Foundation 250 2.484 g/30mL; .36 g/30mL 58411-0573-10 SHISEIDO 1 bottle — — FDA listed —
Shiseido Synchro Skin Radiant Lifting Foundation 340 2.484 g/30mL; .36 g/30mL 58411-0578-10 SHISEIDO 1 bottle — — FDA listed —
Shiseido Synchro Skin Radiant Lifting Foundation 440 2.484 g/30mL; .36 g/30mL 58411-0584-10 SHISEIDO 1 bottle — — FDA listed —
Shiseido Synchro Skin Radiant Lifting Foundation 550 2.484 g/30mL; .36 g/30mL 58411-0591-10 SHISEIDO 1 bottle — — FDA listed —
Shiseido Synchro Skin Radiant Lifting Foundation 560 2.484 g/30mL; .36 g/30mL 58411-0592-10 SHISEIDO 1 bottle — — FDA listed —
Shiseido Synchro Skin Radiant Lifting Foundation 350 2.484 g/30mL; .36 g/30mL 58411-0579-10 SHISEIDO 1 bottle — — FDA listed —
Shiseido Synchro Skin Radiant Lifting Foundation 360 2.484 g/30mL; .36 g/30mL 58411-0580-10 SHISEIDO 1 bottle — — FDA listed —
Shiseido Synchro Skin Radiant Lifting Foundation 430 2.484 g/30mL; .36 g/30mL 58411-0583-10 SHISEIDO 1 bottle — — FDA listed —
Shiseido Synchro Skin Radiant Lifting Foundation 520 2.484 g/30mL; .36 g/30mL 58411-0588-10 SHISEIDO 1 bottle — — FDA listed —
Shiseido Synchro Skin Radiant Lifting Foundation 120 2.484 g/30mL; .36 g/30mL 58411-0564-10 SHISEIDO 1 bottle — — FDA listed —
Shiseido Synchro Skin Radiant Lifting Foundation 450 2.484 g/30mL; .36 g/30mL 58411-0585-10 SHISEIDO 1 bottle — — FDA listed —
Shiseido Synchro Skin Radiant Lifting Foundation 530 2.484 g/30mL; .36 g/30mL 58411-0589-10 SHISEIDO 1 bottle — — FDA listed —
Shiseido Synchro Skin Radiant Lifting Foundation 150 2.484 g/30mL; .36 g/30mL 58411-0567-10 SHISEIDO 1 bottle — — FDA listed —
Shiseido Synchro Skin Radiant Lifting Foundation 220 2.484 g/30mL; .36 g/30mL 58411-0570-10 SHISEIDO 1 bottle — — FDA listed —
Shiseido Synchro Skin Radiant Lifting Foundation 320 2.484 g/30mL; .36 g/30mL 58411-0576-10 SHISEIDO 1 bottle — — FDA listed —
Shiseido Synchro Skin Radiant Lifting Foundation 410 2.484 g/30mL; .36 g/30mL 58411-0581-10 SHISEIDO 1 bottle — — FDA listed —
Shiseido Synchro Skin Radiant Lifting Foundation 460 2.484 g/30mL; .36 g/30mL 58411-0586-10 SHISEIDO 1 bottle — — FDA listed —
Shiseido Synchro Skin Radiant Lifting Foundation 160 2.484 g/30mL; .36 g/30mL 58411-0568-10 SHISEIDO 1 bottle — — FDA listed —
Shiseido Synchro Skin Radiant Lifting Foundation 230 2.484 g/30mL; .36 g/30mLthis 58411-0571-10 SHISEIDO 1 bottle — — FDA listed —
Shiseido Synchro Skin Radiant Lifting Foundation 310 2.484 g/30mL; .36 g/30mL 58411-0575-10 SHISEIDO 1 bottle — — FDA listed —
Shiseido Synchro Skin Radiant Lifting Foundation 330 2.484 g/30mL; .36 g/30mL 58411-0577-10 SHISEIDO 1 bottle — — FDA listed —
Shiseido Synchro Skin Radiant Lifting Foundation 510 2.484 g/30mL; .36 g/30mL 58411-0587-10 SHISEIDO 1 bottle — — FDA listed —
Shiseido Synchro Skin Radiant Lifting Foundation 140 2.484 g/30mL; .36 g/30mL 58411-0566-10 SHISEIDO 1 bottle — — FDA listed —
Shiseido Synchro Skin Radiant Lifting Foundation 420 2.484 g/30mL; .36 g/30mL 58411-0582-10 SHISEIDO 1 bottle — — FDA listed —
Shiseido Synchro Skin Radiant Lifting Foundation 540 2.484 g/30mL; .36 g/30mL 58411-0590-10 SHISEIDO 1 bottle — — FDA listed —
Shiseido Synchro Skin Radiant Lifting Foundation 110 2.484 g/30mL; .36 g/30mL 58411-0563-10 SHISEIDO 1 bottle — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

⏳ Availability & generic status

🏛️
2020
On the market since
Sep 2020
📍
2026
Currently FDA-listed
6 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

🔬 Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for OCTINOXATE and TITANIUM DIOXIDE — the ingredient across all brands.

Top reported reactions

Asphyxia1
Blister1
Dyspnoea1
Eye Disorder1
Eye Pain1
Eye Swelling1
Gingival Blister1

Reporter sex

1 reports
Female · 100%
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

📦 Packaging — all sizes for this product

Package NDCDescription Marketing startStatus
58411-0571-10 You're viewing this 1 BOTTLE in 1 CARTON (58411-571-10) / 30 mL in 1 BOTTLE 2020-09-20 Active

🧭 About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available.
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The FDA registers it as 58411-571-10, which is what is printed on the packaging and shown on DailyMed. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero: 58411-0571-10, written without dashes as 58411057110. The Identity section at the top of this page lists every form of this code.
What do the three segments of this NDC mean?
In 58411-0571-10, the first segment (58411) is the labeler code FDA assigned to SHISEIDO AMERICAS CORPORATION; the middle segment (0571) identifies this specific product — its ingredient, strength, and dosage form; and the last segment (10) identifies this exact package size and type. Together they name one specific package of one specific product.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by SHISEIDO AMERICAS CORPORATION. Listing status can change — the directory data on this page refreshes weekly.
Who lists this product with the FDA?
SHISEIDO AMERICAS CORPORATION is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.

📄 FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 📦 Storage and Handling 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose
🎯 Indications and Usage 30 words ▾

Uses helps prevent sunburn if used as directed with other sun protection measures (see Directions ), decreases the risk of skin cancer and early skin aging caused by the sun

⏱️ Dosage and Administration 94 words ▾

Directions For sunscreen use: apply liberally 15 minutes before sun exposure use a water resistant sunscreen if swimming or sweating reapply at least every 2 hours children under 6 months: Ask a doctor Sun Protection Measures . Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF of 15 or higher and other un protection measures including: limit time in the sun, especially from 10 a.m. – 2 p.m. wear long-sleeve shirts, pants, hats, and sunglasses

⚠️ Warnings 67 words ▾

Warnings For external use only Do not use on damaged or broken skin When using this product keep out of eyes. Rinse with water to remove. Stop use and ask a doctor if rash occurs. Keep out of reach of children. If product is swallowed, get medical help or contact a Poison Control Center right away. Flammable : Do not use near heat, flame or while smoking

📦 Storage and Handling 14 words ▾

Other information protect this product in this container from excessive heat and direct sun.

🧪 Active Ingredient 10 words ▾

Active ingredients Purpose OCTINOXATE 6.9% Sunscreen TITANIUM DIOXIDE 1.0% Sunscreen

🧪 Inactive Ingredients 36 words ▾

Inactive Ingredients WATER▪DIMETHICONE▪DIPHENYLSILOXY PHENYL TRIMETHICONE▪GLYCERIN▪TRIFLUOROPROPYLDIMETHYL/TRIMETHYLSILOXYSILICATE▪BUTYLENE GLYCOL▪HYDROGENATED POLYDECENE▪PEG-10 DIMETHICONE▪BIS-BUTYLDIMETHICONE POLYGLYCERYL-3▪DISTEARDIMONIUM HECTORITE▪ERYTHRITOL▪XYLITOL▪SORBITAN SESQUIISOSTEARATE▪POLYQUATERNIUM-51▪CITRUS UNSHIU PEEL EXTRACT▪THYMUS SERPYLLUM EXTRACT▪FAGUS SYLVATICA BUD EXTRACT▪HYDROLYZED CONCHIOLIN PROTEIN▪DIMETHICONE/VINYL DIMETHICONE CROSSPOLYMER▪DIMETHICONE/PEG-10/15 CROSSPOLYMER▪BARIUM SULFATE▪SYNTHETIC FLUORPHLOGOPITE▪ALUMINUM HYDROXIDE▪POLYSILICONE-2▪DISODIUM EDTA�STEARIC ACID▪CALCIUM ALUMINUM BOROSILICATE▪TOCOPHEROL▪DIPROPYLENE GLYCOL▪TRIETHOXYCAPRYLYLSILANE▪TRIETHOXYSILYLETHYL POLYDIMETHYLSILOXYETHYL DIMETHICONE▪BHT▪ALUMINA▪POLYMETHYLSILSESQUIOXANE▪PHENOXYETHANOL▪TITANIUM DIOXIDE▪IRON OXIDES▪MICA▪

🎯 Purpose 10 words ▾

Active ingredients Purpose OCTINOXATE 6.9% Sunscreen TITANIUM DIOXIDE 1.0% Sunscreen

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗
← 58411-0570-10 · SHISEIDO 58411-0572-10 · SHISEIDO →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.